GLD vs KNSA
SPDR® Gold Shares (GLD) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
GLD does not have a complete income-statement cache yet.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
GLD currently screens at market cap $0. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the GLD and KNSA stock pages for the full models.
Not investment advice.